Edition:
United States

Pulmatrix Inc (PULM.OQ)

PULM.OQ on NASDAQ Stock Exchange Global Market

0.39USD
21 Sep 2018
Change (% chg)

-- (--)
Prev Close
$0.39
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
191,021
52-wk High
$2.38
52-wk Low
$0.28

Latest Key Developments (Source: Significant Developments)

Pulmatrix Q1 Loss Per Share $0.24
Friday, 11 May 2018 09:00am EDT 

May 11 (Reuters) - Pulmatrix Inc ::PULMATRIX REPORTS Q1 2018 RESULTS.Q1 REVENUE $200,000.QTRLY LOSS PER SHARE $0.24.  Full Article

Pulmatrix Reports 2017 Financial Results; Provides 2018 Outlook On Pulmonary Disease Pipeline
Tuesday, 13 Mar 2018 04:43pm EDT 

March 13 (Reuters) - Pulmatrix Inc ::PULMATRIX REPORTS 2017 FINANCIAL RESULTS; PROVIDES 2018 OUTLOOK ON PULMONARY DISEASE PIPELINE.PULMATRIX INC - PHASE 2A STUDY EXPECTED TO BEGIN IN Q4-2018 FOR PULMAZOLE.PULMATRIX INC - EXPECT NON-CLINICAL SAFETY DATA ON PUR1800 IN SECOND HALF OF 2018.PULMATRIX INC - FY NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS $0.93 .  Full Article

Pulmatrix posts Q3 net loss of $0.22 per share
Thursday, 9 Nov 2017 04:30pm EST 

Nov 9 (Reuters) - Pulmatrix Inc :Pulmatrix provides Q3 2017 highlights and Q3 2017 updated financials.Q3 revenue $300,000 versus $100,000.Qtrly ‍net loss per share attributable to common stockholders $0.22​.As of September 30, 2017, Pulmatrix had $6.4 million in cash and cash equivalents, compared to $4.2 million as of December 31, 2016​.  Full Article

Pulmatrix says generated no revenue in Q2 of 2017
Friday, 4 Aug 2017 08:55am EDT 

Aug 4 (Reuters) - Pulmatrix Inc :Pulmatrix provides 2017 company year-to-date highlights and q2 2017 updated financials.Generated no revenues in Q2 of 2017, compared to $0.3 million for Q2 of 2016.Qtrly loss per share $0.29.Decreased qtrly revenue directly related to conclusion of clinical study funded under collaboration agreement to develop PUR0200 for COPD.As of June 30, 2017, Pulmatrix had $11.0 million in cash and cash equivalents, compared to $4.2 million as of December 31, 2016​.  Full Article

Pulmatrix reports qtrly loss per share $0.21
Friday, 5 May 2017 08:55am EDT 

May 5 (Reuters) - Pulmatrix Inc : :Pulmatrix reports Q1 2017 financial results.Qtrly loss per share $0.21.Pulmatrix Inc - pulmatrix generated no revenues in Q1 of 2017, compared to $0.4 million for Q1 of 2016.  Full Article

Pulmatrix reports 2016 financial results provides
Friday, 10 Mar 2017 08:55am EST 

Pulmatrix Inc : Pulmatrix reports 2016 financial results; provides 2017 outlook on pulmonary disease pipeline .Pulmatrix inc- intends to seek a pre-ind meeting with FDA to inform U.S. Clinical development path for pur0200 in second half of 2017.  Full Article

BRIEF-Pulmatrix Q1 Loss Per Share $0.24

* QTRLY LOSS PER SHARE $0.24 Source text for Eikon: Further company coverage: